The interior of a cell is packed with proteins and nucleic acids, such as RNA, all of which need to perform specific ...
They observe how the mobile DNA LINE-1 copies its sequence in human cells, revealing the precise mechanism of the ORF2p gene.
A study found that covid-19 vaccines appeared to awaken the immune system in lung and skin cancer patients, helping them live ...
Researchers have developed a DNA-based therapy that targets the PCSK9 gene to lower cholesterol naturally. Using polypurine ...
The chief technology officer and co-founder explained the technology and design choices that went into Biolinq’s device, ...
Indian Defence Review on MSN
Dolphins Are Losing Their Minds — Scientists Link Alzheimer’s-Like Brain Damage to Algal Toxins
Florida dolphins stranded during algal blooms show brain changes linked to Alzheimer’s, revealing a potential link between ...
Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (Atea or Company), a clinical-stage biopharmaceutical company engaged in the discovery and development of oral antiviral therapeutics for serious viral ...
In a readout of data from the phase 2 BNT111-01 trial (NCT04526899) presented at the 2025 European Society for Medical ...
MHH scientists improve three variants of the CRISPR-Cas9 system for more targeted and effective biomedical application.
Welltica+ on MSN
Study reveals a new, gentle method to lower bad cholesterol
A new DNA-based therapy could cut cholesterol nearly in half—without relying on statins or causing side effects.
Oncolytics Biotech® Inc. (NASDAQ: ONCY) (“Oncolytics” or the “Company”), a clinical-stage immunotherapy company developing ...
Oncolytics Biotech® Inc. (NASDAQ: ONCY) ("Oncolytics" or the "Company"), a clinical-stage immunotherapy company developing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback